刊名:The Journal of Steroid Biochemistry and Molecular Biology
出版年:2017
出版时间:January 2017
年:2017
卷:165
期:part_PA
页码:121-123
全文大小:251 K
卷排序:165
文摘
Dexamethasone treatment before 9 gestational weeks prevents virilization in females affected with classical CAH. Prenatal dexamethasone treatment has little to no adverse side effects. Noninvasive methods using fetal DNA from maternal blood have been developed for early prenatal genetic testing. Early noninvasive prenatal genetic testing avoids prescription of dexamethasone to mothers carrying male or unaffected female fetuses.